Edwin Cuppen Group

Cancer genetics

Our Focus

The Cuppen group investigates the causes and consequences of genetic variation under normal and disease conditions. We are using the latest next-generation sequencing based technologies for studying the basis and molecular mechanisms of specific human diseases with a specific focus on cancer. Interpretation of alterations at the single base letter and structural level in both protein-coding and regulatory domains is one of the main challenges that we address using systematic integrative experimental and computational approaches. Furthermore, we are studying the origin and mechanisms by which de novo genetic variation is induced.

Our research is performed in a highly collaborative fashion both within the group and with other research groups and clinical laboratories and researchers on a local, national and international level. These collaborations are important for translating fundamental knowledge into clinical practice and routine diagnostics.

Our main fundamental research questions are:

  • What are the mutation rates and processes in healthy and pre-malignant cells in different tissues during the process of aging?
  • How do these mutations contribute to disease and aging and what are the mechanisms that protect normal cells from disfunctioning?
  • How do mutations contribute to tumor characteristics including response to treatment?
  • What are the causes of complex structural variation (SVs)
  • What are the consequences of complex SVs on genome/gene function in congenital disease

We address these questions utilizing primary patient material, stem cell-based technologies, including organoids and patient-derived induced pluripotent stem cells. We apply whole genome sequencing technologies to obtain a comprehensive overview of all types of genetic variants. The effects of single nucleotide variants and structural variants are determined by sequencing-based technologies such as RNA-seq, Chip-seq et cetera. Such data sets are integrated and analyzed in the context of large bodies of public data by bioinformaticians and computational scientists to dissect putative mechanism and define hypotheses on potential causal relationships. We envision that these approaches will contribute to increasing fundamental biological knowledge, improving diagnostics and the development of personalized medicine.

Arne van Hoeck Post Doc
Ewart Kuijk Post Doc
Ies Nijman Manager Sequencing Facility
Luan Nguyen Phd Student
Lisanne de la Fonteijne Technician
Nicolle Besselink Technician
Robin Geene Research Analyst
Roel Janssen Bioinformatician
Sander Boymans Bioinformatician
Sharon Christensen Phd Student
Sjors Middelkamp Post Doc
Contact Information
Edwin Cuppen Oncode Investigator

More Research

Research Strategy
Focus and Approach
Over 800 scientists working under a single strategy. Oncode is all about uniting efforts and bringing focus to research.
Support Programme
Our supporting programmes
New plans that help fulfil Oncode's objectives get our full support. Young talents are matched with mentors on the basis of their personal endeavours.